ASCO PRESENTATION:
Saturday, May 30, 2015
Time: 3:00 PM–4:00 PM
Company: Northwest Biotherapeutics
Presentation Title: Dendritic Cell-Based Immunotherapy, DCVax®, for Resectable and Non-Resectable Solid Tumors
Presenter: Marnix L. Bosch, MBA, PhD, Chief Technical Officer, Northwest Biotherapeutics